Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure... see more

Recent & Breaking News (TSXV:AVCR)

Avricore Health Refocuses Strategy to Unlock Growth Potential

GlobeNewswire 10 days ago

Avricore Health Recognized in Deloitte's 2024 Technology Fast 50(TM) Companies to Watch

GlobeNewswire November 6, 2024

Avricore Grants Options

GlobeNewswire August 30, 2024

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

GlobeNewswire August 29, 2024

AVRICORE HEALTH CORPORATE UPDATE - COMPANY ACHIEVES PROFITABILITY

GlobeNewswire June 3, 2024

Avricore Health Corporate Update and Audited Results for 2023

GlobeNewswire April 30, 2024

HealthTab(TM) Signs Agreement for More Rexall® Pharmacy Locations

GlobeNewswire April 4, 2024

Avricore Health Corporate Update - Company Demonstrates Strong Growth

GlobeNewswire November 30, 2023

HealthTab(TM) Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

GlobeNewswire September 15, 2023

Avricore Health Corporate Update - Mid-Year Review Demonstrates Company on Right Track

GlobeNewswire August 30, 2023

HealthTab(TM) Signs Reseller Agreement With Abbott to Support UK Expansion

GlobeNewswire August 8, 2023

Avricore's HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom

GlobeNewswire August 3, 2023

HealthTab(TM) to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights

GlobeNewswire July 19, 2023

Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members

GlobeNewswire June 21, 2023

Avricore Grants Options

GlobeNewswire May 15, 2023

Avricore Health Corporate Updates on Audited Results for 2022

GlobeNewswire May 2, 2023

Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection

GlobeNewswire March 23, 2023

Avricore Health Makes the Grade on 2023 TSX Venture 50

GlobeNewswire February 21, 2023

Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives

GlobeNewswire February 1, 2023

Avricore Health Reports Third-Quarter 2022 Results

GlobeNewswire November 29, 2022